Skip Navigation

Muscular Dystrophy Coordinating Committee (MDCC) Meeting - November 2015

Loading... Loading video...


Chapter Description Position
1 Thumbnail image Welcome and Introductions - Steve Katz, Acting Chair MDCC 0:00:05
2 Thumbnail image Eunice Kennedy Shriver National Institute of Child Health and Human Development - Catherine Spong, Acting Director NICHD 0:17:44
3 Thumbnail image MDCC Action Plan: Member Organization Mission Landscape and Progress Monitoring - Glen Nuckolls 0:41:38
4 Thumbnail image MDF Patient-Centered Therapy Development Meeting Report - Sharon Hesterlee, Myotonic Dystrophy Foundation 1:53:30
5 Thumbnail image FSHD Trial Readiness Meeting Report - Rabi Tawil, University of Rochester 2:17:18
6 Thumbnail image FSHD International Research Consortium and Planning Workshop Report - Dan Perez, FSH Society 2:41:00
7 Thumbnail image FDA Biomarker Qualification Program - Shashi Amur, Center for Drug Evaluation and Research, FDA 3:03:03
8 Thumbnail image Imaging Biomarkers for the Muscular Dystrophies - Krista Vandenborne, University of Florida 3:40:11
9 Thumbnail image Biochemical Biomarkers for the Duchenne Muscular Dystrophies - Yetrib Hathout, Children’s National Medical Center, DC 4:26:10
10 Thumbnail image NIH Office of Rare Disease Research - Petra Kaufmann, Director ORDR, NCATS 5:07:18